This trial studies the effectiveness of using a mobile health application (app) called Symptom Tracker (Insight) mHealth to monitor symptoms of coronavirus disease 2019 (COVID-19) in cancer patients. This study also aims to triage patients for early COVID testing and determine the effect of increased vital sign monitoring and COVID19 specific symptom monitoring in COVID19 positive patients on disease severity and length of recovery from viral illness. Symptom Tracker (Insight) mHealth app, may result in earlier detection of the COVID19 virus and increase the chances of delivering medical care early in the course of the illness, which may improve how patients recover from COVID19.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04397614.
PRIMARY OBJECTIVES:
I. Determine the feasibility, ease of use, and perceived utility of the Symptom Tracker (Insight) mHealth app to monitor symptoms and health risk behaviors for up to 500 patients who are receiving chemotherapy to treat cancer.
II. Examine participant characteristics and outcomes of those who do and do not test positive for COVID-19 during the 24-week monitoring period.
III. Collaboratively document and share lessons learned regarding the impact of the COVID-19 pandemic on cancer care delivery via telemedicine and mHealth technology.
OUTLINE:
Patients complete daily monitoring of symptoms and weekly monitoring of health risk factors over 15-30 minutes via the Symptom Tracker (Insight) mHealth app for 24 weeks. Patients who screen positive for COVID-19 are triaged to emergency or non-emergency medical treatment. COVID-19 positive patients identified for non-emergent medical treatment receive a study-supplied device to measure oxygen level and heart rate, and enter vital signs data daily via app.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationUniversity of Oklahoma Health Sciences Center
Principal InvestigatorKatherine Marie Moxley
